Short answer: Sex, yes, quite clearly. Multiple studies using precise isotope-tracking methods have consistently found that women convert ALA into EPA and DHA meaningfully more efficiently than men do, an effect researchers attribute largely to estrogen. Age is a more complicated story. Older theories and some mechanistic research suggest the relevant enzymes lose activity as people get older, but more recent studies actually measuring blood omega-3 levels across age groups haven’t found a simple, consistent decline, which makes age a genuinely less settled factor than sex in this particular area of research.
The Sex Difference Is Well Established
This is one of the more consistently replicated findings in omega-3 metabolism research. A comprehensive review of ALA conversion studies found that fractional conversion of ALA to EPA varies between 0.3 and 8 percent in men, with conversion to DHA under 4 percent and often undetectable, while women convert up to 21 percent of ALA to EPA and up to 9 percent to DHA. That’s a substantial gap, not a marginal statistical difference. Researchers have traced much of this difference to hormonal effects; a study using ovariectomized mice found that estrogen treatment resulted in significantly higher DHA levels in serum and liver tissue, supporting a direct hormonal role in this conversion advantage. This is a large part of why premenopausal women in particular tend to show notably better ALA-to-DHA conversion than men or postmenopausal women, and it’s a genuinely useful piece of context for anyone trying to understand why the same amount of flaxseed oil might work differently for different people.
Age: A Less Settled Picture Than You’d Expect
Age is where this topic gets more genuinely uncertain, and it’s worth being upfront about that rather than flattening it into a simple story. For decades, a long-standing hypothesis in aging research held that the key enzyme in this pathway, delta-6 desaturase, gradually loses activity as people age. This idea traces back to a foundational 1981 paper that proposed delta-6 desaturase levels fall with age, based on findings in aging rat tissue, and framed this decline as a potential key factor in the broader aging process. Subsequent research reviewing omega-3 metabolism in the context of neurodegenerative disease has generally supported this framing, noting that delta-6 desaturase activity decreases with age, with a more pronounced effect in women, meaning dietary supplementation with preformed omega-3s becomes increasingly important later in life.
Here’s the honest complication, though: this mechanistic story doesn’t always hold up cleanly when researchers actually measure omega-3 levels in people’s blood across different ages. A 2026 clinical study analyzing blood fatty acid profiles across a real population found that participants aged 65 and older actually showed higher total omega-3 levels, including both EPA and DHA, along with a positive association between age and one specific desaturase activity index, even as a different enzyme step, elongation, showed an inverse relationship with age. That’s a meaningfully different picture from a straightforward decline, and it suggests that real-world omega-3 status in older adults depends on more than just enzyme activity alone; diet, health status, and other lifestyle factors likely play a substantial role too, potentially outweighing or offsetting any underlying enzymatic changes.
What This Means in Practice
Taken together, sex is a factor worth taking seriously and building into expectations: men and postmenopausal women, in particular, are working with a meaningfully less efficient conversion pathway than premenopausal women. Age is a real area of ongoing scientific interest, but it isn’t nearly as settled or predictable a factor, and the research genuinely points in more than one direction depending on whether you’re looking at cellular mechanisms or actual blood test results in living populations.
- Sex has a well-documented, substantial effect on ALA conversion efficiency. Women, particularly premenopausal women, convert ALA to EPA and DHA notably better than men do, likely due to estrogen’s influence on the relevant enzymes.
- Age’s effect on conversion is genuinely less settled in the research. Mechanistic studies suggest declining enzyme activity, but real-world blood level data doesn’t always confirm a simple downward trend.
- For men, or anyone whose conversion efficiency may be reduced for other reasons, a preformed source of EPA and DHA sidesteps this variability entirely. Since it doesn’t depend on the conversion pathway at all, it delivers a more predictable result regardless of sex or age-related enzyme activity.
If there’s one clear takeaway here, it’s that “conversion efficiency” isn’t a single fixed number that applies to everyone equally; it’s shaped by real biological differences between individuals, some well understood and others still actively being researched.
